Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Safety and Efficacy of RM-004 Cells for the Treatment of Hemoglobin H-Constant Spring Disease

NCT06107400 is registered in ClinicalTrials.gov with The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army as lead sponsor.

NCT NCT06107400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06107400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Safety and Efficacy of RM-004 Cells for the Treatment of Hemoglobin H-Constant Spring Disease
Lead sponsor
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Phase
Phase 1
Overall status
Recruiting
Start date
October 8, 2023
Completion date
October 31, 2026
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alpha thalassemia hemoglobin h constant spring, hemoglobinopathies, hereditary diseases